USPTO Examiner AHMED TASNIM M - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19028678DRUG DELIVERY DEVICE WITH FEEDBACK MECHANISMJanuary 2025April 2025Allow300NoNo
19028803DRUG DELIVERY DEVICE WITH FEEDBACK MECHANISMJanuary 2025March 2025Allow200NoNo
18815209THREE-WAY CONNECTING ASSEMBLY AND WEARABLE BREAST PUMPAugust 2024April 2025Allow810NoNo
18838019SECUREMENT DEVICE, KIT COMPRISING SECUREMENT DEVICE, AND METHOD OF SECURING SECUREMENT DEVICE ON SKIN OF USERAugust 2024February 2025Allow600NoNo
18732871HARD-PACKAGED SAFETY NEEDLE DEVICEJune 2024April 2025Allow1110NoNo
18668582NEEDLE CAPTURE SAFETY INTERLOCK FOR CATHETERMay 2024April 2025Allow1110NoNo
18665931MEDICAMENT DELIVERY DEVICE COMPRISING A VISUAL INDICATORMay 2024June 2025Allow1310NoNo
18660854ELECTRONIC ADD-ON MODULE AND ASSEMBLY OF AN ELECTRONIC ADD-ON MODULE AND A DRUG DELIVERY DEVICEMay 2024September 2024Allow400NoNo
18620210ROTATABLE COLLAR FOR INJECTION DEVICESMarch 2024October 2024Allow711NoNo
18618533Support Devices for Bodily Fluid Transfer Systems and Methods of Using the SameMarch 2024January 2025Allow1010NoNo
18595845SYRINGES CONFIGURED TO INHIBIT FORWARD PLUNGER MOVEMENTMarch 2024May 2025Allow1430NoNo
18592467SYSTEMS AND METHODS FOR IMPROVING OPERATION OF INFUSION PUMPSFebruary 2024January 2025Allow1110NoNo
18587345SYSTEMS, METHODS, AND APPARATUS FOR ACCESS TO IMPLANTED ACCESS PORTFebruary 2024September 2024Allow700NoNo
18587273SYSTEMS, METHODS, AND APPARATUS FOR DETECTION OF IMPLANTED ACCESS PORT AND USE THEREOFFebruary 2024October 2024Allow700NoNo
18415452AUTO INJECTOR WITH ADAPTABLE AIR-SHOT MECHANISMJanuary 2024October 2024Allow900NoNo
18409480TORQUE DRIVEN DRUG DELIVERY DEVICEJanuary 2024March 2025Allow1420NoNo
18540467Medicament Injection DeviceDecember 2023April 2025Allow1611NoNo
18538836CATHETER HOUSINGDecember 2023December 2024Allow1310YesNo
18534155DRUG DELIVERY DEVICEDecember 2023January 2025Allow1420YesNo
18524436System and Method of Utilizing ECG Signal for Static Catheter Tip ConfirmationNovember 2023November 2024Allow1210NoNo
18513080MEDICATION DELIVERY DEVICE INCLUDING DISPOSABLE AND REUSABLE PORTIONSNovember 2023April 2025Allow1711NoNo
18487987METHOD AND APPARATUS FOR TREATING GENITOURINARY PROBLEMSOctober 2023October 2024Allow1210YesNo
18480290CATHETER SYSTEMS, KITS, AND METHODS FOR GAINING ACCESS TO A VESSELOctober 2023November 2024Allow1410NoNo
18472572Stretch Valve Balloon Catheter and Methods for Producing and Using SameSeptember 2023September 2024Allow1110NoNo
18459479SELF-CLEARING CATHETERS AND METHODS OF USE THEREOFSeptember 2023March 2025Allow1921NoNo
18239717INJECTION DEVICE WITH DOSE INTERRUPTION FAIL SAFEAugust 2023December 2024Allow1510NoNo
18239055MICRO-VOLUME INJECTORS WITH DOSE GUIDANCE AND METHODS FOR USEAugust 2023October 2024Allow1410NoNo
18363971HEMOSTASIS VALVE ORIENTATION RELATIVE TO THE FLUID SPACE IN A INTRODUCER SHEATHAugust 2023June 2025Allow2220YesNo
18228039BENT FLUID PATH ADD ON TO A PREFILLED FLUID RESERVOIRJuly 2023September 2024Allow1310NoNo
18220736Filtering Needle Assembly with Seal PlugJuly 2023October 2023Allow300NoNo
18343614MEDICAL INSTRUMENT AND ASSOCIATED METHODJune 2023March 2025Allow2020NoNo
18205957INJECTION DEVICE WITH FLEXIBLE DOSE SELECTIONJune 2023December 2024Allow1810NoNo
18205966INJECTION DEVICE WITH FLEXIBLE DOSE SELECTIONJune 2023December 2024Allow1810NoNo
18139738DELIVERY DEVICES FOR THERAPEUTIC SUBSTANCESApril 2023January 2025Allow2110NoNo
18306760DRIVE RIBBON FOR MOVING PISTON WITHIN CONTAINERApril 2023May 2024Allow1200NoNo
18134512FLEXIBLE CANNULA INSERTION DEVICE, SYSTEM AND PROCESSApril 2023August 2024Allow1610NoNo
18130237Method of Accessing the Left Atrium with a Multi-Directional Steerable CatheterApril 2023May 2024Allow1410NoNo
18129128SAFETY DEVICE WITH COLLAPSIBLE HOUSING AND TRIGGER ACTIVATIONMarch 2023July 2024Allow1600NoNo
18246589MEDICATION DELIVERY DEVICE INCLUDING DISPOSABLE AND REUSABLE PORTIONSMarch 2023August 2023Allow500YesNo
18109118NEEDLE CAPTURE SAFETY INTERLOCK FOR CATHETERFebruary 2023February 2024Allow1200NoNo
18107429DEVICE FOR CONTROLLABLY DEPLOYING EXPANDABLE IMPLANTSFebruary 2023August 2024Allow1810NoNo
18161034Low Profile Lumen Access CatheterJanuary 2023May 2024Allow1610NoNo
18097910INJECTION DEVICE AND INJECTION SOLUTION TRANSFERRING SYSTEMJanuary 2023September 2024Allow2010NoNo
18004214AUTOMATIC INJECTION DEVICE WITH REUSABLE PORTIONJanuary 2023April 2023Allow400NoNo
18062131DRAINAGE CATHETER HUB WITH A SEMI-COMPRESSED SUTURE SEALDecember 2022April 2024Allow1610NoNo
18075377INJECTION DEVICES AND SYSTEMS AND METHODS FOR USING THEMDecember 2022January 2025Allow2610NoNo
17964217NEEDLE CAPTURE SAFETY INTERLOCK FOR CATHETEROctober 2022July 2024Allow2120NoNo
17958817INJECTION DEVICE WITH AN ACOUSTIC FEEDBACK ARRANGEMENTOctober 2022April 2024Allow1920YesNo
17947574MEDICATION DELIVERY DEVICESeptember 2022August 2024Allow2320NoNo
17943027Medicament Injection DeviceSeptember 2022December 2024Allow2711NoNo
17801290INJECTION DEVICE INCORPORATING A NEEDLE SHIELD REMOVERAugust 2022June 2025Allow3400NoNo
17886586Wearable Drug Delivery Device with Pressurized Fluid DispensingAugust 2022May 2024Allow2210NoNo
17816360AUTO INJECTOR WITH ADAPTABLE AIR-SHOT MECHANISMJuly 2022November 2023Allow1600YesNo
17872795Flexible Modules for Injection DevicesJuly 2022October 2024Allow2600NoNo
17751060Upper Extremity Access Angiographic CatheterMay 2022October 2024Allow2900NoNo
17663812DEVICE FOR CONTROLLABLY DEPLOYING EXPANDABLE IMPLANTSMay 2022November 2022Allow610YesNo
17728428HME DEVICE FOR USE IN A BREATHING CIRCUIT OF A VENTILATION SYSTEMApril 2022June 2024Allow2621NoNo
17727423Injection DeviceApril 2022January 2024Allow2110NoNo
17725057ENEMA DEVICE, AND A DELIVERY CONTAINER FOR USE IN SAID ENEMA DEVICEApril 2022November 2023Allow1911NoNo
17699708MICRONEEDLE ARRAY ASSEMBLY AND FLUID DELIVERY APPARATUS HAVING SUCH AN ASSEMBLYMarch 2022April 2023Allow1300YesNo
17698550Support Devices for Bodily Fluid Transfer Systems and Methods of Using the SameMarch 2022January 2024Allow2211NoNo
17696521INJECTOR NEEDLE CAP AND/OR LINER REMOVERMarch 2022March 2024Allow2421YesNo
17691653Micro-cannula and Pilot Needle ManagerMarch 2022March 2024Allow2510YesNo
17666655SUPPOSITORY APPLICATORFebruary 2022April 2025Allow3910NoNo
17586068MEDICAL INJECTION SYSTEMJanuary 2022March 2025Allow3800NoNo
17575956Delivery System For A Pharmaceutical, Holistic Or Medicinal ComponentJanuary 2022April 2022Allow320YesNo
17568003SHIELD ASSEMBLY FOR SYRINGEJanuary 2022October 2024Allow3321YesNo
17622242UNILATERAL-DRIVEN DRUG INFUSION DEVICEDecember 2021March 2025Allow3800NoNo
17622385AWAKENING ELECTRONICS IN AN INJECTION DEVICEDecember 2021May 2025Allow4110NoNo
17552040State Indicator and Drug Delivery Device with a State Indicator and a Method for Manufacturing a Drug Delivery DeviceDecember 2021January 2024Allow2520YesNo
17618756PERIPHERALLY INSERTED CENTRAL-LINE CATHETER (PICC) LINE SUPPORT APPARATUSDecember 2021June 2025Allow4210NoNo
17616367Apparatus for Removing a Needle ShieldDecember 2021April 2025Allow4110NoNo
17520655MEDICAMENT DELIVERY DEVICE COMPRISING A VISUAL INDICATORNovember 2021February 2024Allow2721NoNo
17516787COLON CLEANING SYSTEM WITH AUTOMATIC SELF-PURGING FEATURESNovember 2021October 2023Allow2300NoNo
17517242ANTI-MICROBIAL IV TUBING PROTECTION SYSTEMNovember 2021June 2022Allow710NoNo
17499776PERCUTANEOUS ACCESS SYSTEMS AND METHODSOctober 2021August 2023Allow2210YesNo
17498449ASSEMBLIES AND METHODS FOR INFUSION PUMP SYSTEM ADMINISTRATION SETSOctober 2021June 2023Allow2000NoNo
17497746SPRING CANNULAEOctober 2021July 2023Allow2110NoNo
17479131GASTRIC RETENTIVE DEVICESSeptember 2021July 2024Abandon3421NoNo
17479924Dwell TimerSeptember 2021March 2025Allow4110NoNo
17472629Multi-Directional Steerable CatheterSeptember 2021February 2023Allow1710NoNo
17472516Medicament Injection DeviceSeptember 2021July 2023Allow2210NoNo
17461829STRETCH VALVE BALLOON CATHETER AND METHODS FOR PRODUCING AND USING SAMEAugust 2021June 2023Allow2110YesNo
17433479DRUG DELIVERY DEVICE WITH MEANS FOR DETERMINING EXPELLED DOSEAugust 2021October 2024Abandon3810NoNo
17395670BENT FLUID PATH ADD ON TO A PREFILLED RESERVOIRAugust 2021May 2023Allow2120YesNo
17392374INJECTOR SYSTEMAugust 2021March 2023Allow2000NoNo
17424466INFUSION DEVICE FOR ADMINISTERING A MEDICAL FLUID TO A PATIENTJuly 2021January 2025Allow4210NoNo
17379950PADDLE SHAPED MEDICINAL DISPENSERJuly 2021February 2022Allow720YesNo
17376115METHOD OF DELIVERING A THERAPEUTIC AGENT TO A SOLID TUMOR FOR TREATMENTJuly 2021March 2025Allow4460NoNo
17415358DEVICE FOR THE NEEDLE TUBE OF A SYRINGEJune 2021October 2024Allow4010NoNo
17344333DRUG DELIVERY DEVICEJune 2021April 2025Abandon4610NoNo
17342449MEDICINE INJECTION DEVICES, SYSTEMS, AND METHODS FOR MEDICINE ADMINISTRATION AND TRACKINGJune 2021October 2023Allow2801NoNo
17342435INJECTION PENS FOR MEDICINE ADMINISTRATION AND TRACKINGJune 2021October 2024Allow4020YesNo
17337273Catheter Insertion Device Including Retractable NeedleJune 2021October 2022Allow1600NoNo
17293027Catheter Redirection Systems for Use in Gaining Access to Cerebral ArteriesMay 2021September 2024Allow4000NoNo
17315867Hypodermic Safety NeedleMay 2021October 2023Allow2911NoNo
17315856Hard-Packaged Safety Needle DeviceMay 2021February 2024Allow3310NoNo
17316706Low Profile Lumen Access CatheterMay 2021September 2022Allow1700NoNo
17314860INTRADERMAL JET INJECTION ELECTROPORATIONMay 2021April 2024Allow3510NoNo
17307886FLEXIBLE CANNULA INSERTION DEVICE, SYSTEM AND PROCESSMay 2021January 2023Allow2010YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner AHMED, TASNIM M.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
1
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
19.1%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
12
Allowed After Appeal Filing
3
(25.0%)
Not Allowed After Appeal Filing
9
(75.0%)
Filing Benefit Percentile
33.3%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 25.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner AHMED, TASNIM M - Prosecution Strategy Guide

Executive Summary

Examiner AHMED, TASNIM M works in Art Unit 3783 and has examined 404 patent applications in our dataset. With an allowance rate of 83.7%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 32 months.

Allowance Patterns

Examiner AHMED, TASNIM M's allowance rate of 83.7% places them in the 52% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by AHMED, TASNIM M receive 1.65 office actions before reaching final disposition. This places the examiner in the 45% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by AHMED, TASNIM M is 32 months. This places the examiner in the 34% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +7.3% benefit to allowance rate for applications examined by AHMED, TASNIM M. This interview benefit is in the 37% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 27.7% of applications are subsequently allowed. This success rate is in the 39% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 43.7% of cases where such amendments are filed. This entry rate is in the 60% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 76% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 88.9% of appeals filed. This is in the 80% percentile among all examiners. Of these withdrawals, 62.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 34.0% are granted (fully or in part). This grant rate is in the 28% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 42% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 3.0% of allowed cases (in the 71% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.